Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

IRCM researchers discover a nerve cell's internal clock

A team of IRCM researchers, led by Dr. Fr-d-ric Charron, recently uncovered a nerve cell's internal clock, used during embryonic development.

22 Nov 2012

Somnogen induces sleep in patients with primary hypersomnia

Researchers at Emory University School of Medicine have discovered that dozens of adults with an elevated need for sleep have a substance in their cerebrospinal fluid that acts like a sleeping pill.

22 Nov 2012

Promising results for pneumococcal vaccine

Research published in The Lancet shows that the PHiD-CV10 vaccine is highly effective at protecting children against invasive pneumococcal disease.

21 Nov 2012

Simple, accurate testing protocol to determine driving fitness in individuals with MS

A simple, accurate testing protocol to determine driving fitness in individuals with multiple sclerosis is the aim of a three-year study at Georgia Health Sciences University.

21 Nov 2012

HeartWare receives FDA approval for new left ventricular assist device

The U.S. Food and Drug Administration today approved the HeartWare Ventricular Assist System, a left ventricular assist device (LVAD), to support heart function and blood flow in patients with end-stage heart failure who are awaiting a heart transplant.

21 Nov 2012

Pfizer, Bristol-Myers Squibb receive EC approval for ELIQUIS to prevent NVAF-related stroke

Bristol-Myers Squibb and Pfizer announced today that the European Commission has approved ELIQUIS (apixaban) for prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors.

21 Nov 2012

New insights into what causes uncontrollable bleeding in hemophilia patients

New insights into what causes uncontrollable bleeding in hemophilia patients are provided in a study published by Cell Press on November 20th in the Biophysical Journal. By revealing that blood clots spread in traveling waves through vessels, the study offers new strategies that could lead to the development of more effective treatments for hemophilia as well as common cardiovascular disorders.

20 Nov 2012

Generic scale compares manual ability across diagnoses

Researchers have developed a generic manual ability scale unbiased by diagnosis that could allow quantitative comparisons of manual ability between diagnostic groups.

20 Nov 2012

TBI, age-related dementia and stroke fuel neurologic disability in India

The 'Global Perspectives' published in the Nov. 20, 2012 issue of Neurology-, the medical journal of the American Academy of Neurology, features "Neurologic Disability: A Hidden Epidemic for India".

20 Nov 2012

KLF4 genetic factor prevents blood vessels from blockages

Researchers at Case Western Reserve University School of Medicine have identified a genetic factor that prevents blockages from forming in blood vessels, a discovery that could lead to new therapies for cardiovascular diseases.

20 Nov 2012

Ventus Medical introduces Provent Sleep Apnea Therapy in Canada

Ventus Medical is pleased to announce the introduction of its proprietary Provent Sleep Apnea Therapy into Canada. Provent Therapy is an innovative, non-invasive treatment for obstructive sleep apnea (OSA).

20 Nov 2012

Diffusion Pharmaceuticals completes trans sodium crocetinate Phase I trial on glioblastoma

Diffusion Pharmaceuticals LLC, a biotechnology company developing innovative cancer treatments, today announced that it has successfully completed a Phase I clinical trial of its lead compound trans sodium crocetinate (TSC) in nine patients with newly diagnosed primary brain cancer (glioblastoma or GBM).

19 Nov 2012

Treatment-related heart failure risk for rheumatoid arthritis patients revealed

Rheumatoid arthritis patients have no greater risk for heart failure with tumor necrosis factor-alpha therapy than with nonbiologic disease-modifying antirheumatic drugs, research suggests.

19 Nov 2012

Strep detection tests may miss sore throat-causing bacterial strains

Rapid streptococcal antigen detection tests, which are widely used to detect non-group A Lancefield beta-hemolytic streptococci in many developed countries, may be missing clinically important streptococci, say researchers.

19 Nov 2012

Telemedicine program shows promise for patients with concussions in rural Arizona

A program at Mayo Clinic using telemedicine technology is showing promise for patients with concussions in rural Arizona. A case study published in the December 2012 issue of Telemedicine and e-Health validates "teleconcussion" as a useful means to assess concussed patients.

19 Nov 2012

Positive results from Genentech Avastin plus temozolomide Phase III study on glioblastoma

Genentech, a member of the Roche Group, today announced results from the positive Phase III AVAglio study. The study showed Avastin (bevacizumab) in combination with radiation and temozolomide chemotherapy reduced the risk of cancer worsening or death (progression-free survival; PFS) by 36 percent compared to radiation and temozolomide chemotherapy plus placebo>th Annual Meeting of the Society for Neuro-Oncology in Washington, D.C.

19 Nov 2012

ReFIT algorithm improves speed and accuracy of neural prosthetics

When a paralyzed person imagines moving a limb, cells in the part of the brain that controls movement still activate as if trying to make the immobile limb work again. Despite neurological injury or disease that has severed the pathway between brain and muscle, the region where the signals originate remains intact and functional.

19 Nov 2012

NIH-funded scientists develop new treatment to combat autoimmune disorders in mouse model

In a mouse model of multiple sclerosis (MS), researchers funded by the National Institutes of Health have developed innovative technology to selectively inhibit the part of the immune system responsible for attacking myelin-the insulating material that encases nerve fibers and facilitates electrical communication between brain cells.

18 Nov 2012

People with diabetes need a plan to stay healthy during holiday season: Harris Health System

A figurative mine field of savory dishes and desserts await many this holiday season, from pumpkin pies topped with whipped cream, green bean and mushroom casseroles, pork tamales, cranberries and cornbread dressing to fruit salads and oven-roasted turkey.

17 Nov 2012

HHS, SJHH launch integrated Radiology and Nuclear Medicine peer review pilot project

The integrated department of diagnostic services at Hamilton Health Sciences and St. Joseph's Healthcare Hamilton announced today that it is launching a city-wide, integrated Radiology and Nuclear Medicine peer review pilot project.

17 Nov 2012

Stroke News and Research

Further Reading

IRCM researchers discover a nerve cell's internal clock

Somnogen induces sleep in patients with primary hypersomnia

Promising results for pneumococcal vaccine

Simple, accurate testing protocol to determine driving fitness in individuals with MS

HeartWare receives FDA approval for new left ventricular assist device

Pfizer, Bristol-Myers Squibb receive EC approval for ELIQUIS to prevent NVAF-related stroke

New insights into what causes uncontrollable bleeding in hemophilia patients

Generic scale compares manual ability across diagnoses

TBI, age-related dementia and stroke fuel neurologic disability in India

KLF4 genetic factor prevents blood vessels from blockages

Ventus Medical introduces Provent Sleep Apnea Therapy in Canada

Diffusion Pharmaceuticals completes trans sodium crocetinate Phase I trial on glioblastoma

Treatment-related heart failure risk for rheumatoid arthritis patients revealed

Strep detection tests may miss sore throat-causing bacterial strains

Telemedicine program shows promise for patients with concussions in rural Arizona

Positive results from Genentech Avastin plus temozolomide Phase III study on glioblastoma

ReFIT algorithm improves speed and accuracy of neural prosthetics

NIH-funded scientists develop new treatment to combat autoimmune disorders in mouse model

People with diabetes need a plan to stay healthy during holiday season: Harris Health System

HHS, SJHH launch integrated Radiology and Nuclear Medicine peer review pilot project

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News